glp 1 agonists microdose GLP-1 Injections What Is Microdosing GLP-1? Full

However, caution is recommended in the use of SGLT2i in people with a high risk of amputation or skin ulcers in the lower extremities [89]

Simms-Williams N, Treves N, Yin H, et al

Egecioglu E, Engel JA, Jerlhag E

[DOI] [PubMed] [Google Scholar] 97

45 Products that are a combination of a DPP-4 inhibitor and an SGLT2 inhibitor (sitagliptin/ertugliflozin, saxagliptin/dapagliflozin, and linagliptin/empagliflozin) may be used to further lower A1C and provide increased CV benefit in patients who are not meeting A1C goals on dual therapy

2 Metformin (MET) is recommended as the first-line treatment for patients with T2DM due to well-established efficacy, safety, low cost, and data demonstrating a reduction in risk of cardiovascular (CV) events